[ad_1]
drug track of these 33 product sales has been decided to block the system.
European Medicines Agency (EMA) 5 on its warning in July, the pharmaceutical Turkey and Medical Device Authority 'valsartan' active substance had opened a drug-related investigation.
According to the information of the Ministry of Health officials of the correspondent AA, these are the result of the examination started on the basis of carcinogens may include, licensed in Turkey, with different forms of 39, packaging and content 'valsartan' production facility of active substance in China for 33 items has been found that the active ingredient is provided.
The Scientific Committee discussed the drug situation and decided to prevent the sale of blood pressure drugs and cardiac drugs containing valsartan to the Drug Tracking System in order to take the necessary measures quickly.
Officials say the market has active ingredients "valsartan", equivalent products that do not involve risk, and that citizens will suffer from a lack of access.
Source link
